DiaMedica Therapeutics Inc.
Income Statement
| Line Item | FY2018 | FY2017 |
|---|---|---|
| Revenue | $500.0K | — |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $4.5M | $3.2M |
| SG&A Expense | $2.7M | $1.3M |
| Operating Income | $-6.8M | $-4.5M |
| Operating Margin | -1,352.2% | — |
| Interest Expense | — | — |
| Pretax Income | $-5.7M | $-4.3M |
| Income Tax Expense | $80.0K | — |
| Net Income | $-5.7M | $-4.3M |
| Net Margin | -1,146.8% | — |
| EPS (Basic) | $-0.74 | $-0.72 |
| EPS (Diluted) | $-0.74 | $-0.72 |
| Shares Outstanding (Basic) | 12.0M | 6.4M |
| Shares Outstanding (Diluted) | 12.0M | 6.4M |
| Dividends Per Share | — | — |